Cara Therapeutics (CARA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | CSL Limited Reports 13.5% Stake in Cara Therapeutics Inc as of Oct 23 - SEC Filing
ReutersOct 30 16:23 ET
12 Health Care Stocks Moving In Friday's After-Market Session
BenzingaOct 11 16:31 ET
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
BenzingaAug 26 16:30 ET
Marijuana Stock Movers For August 20, 2024
BenzingaAug 20 16:30 ET
Bullish Friday For Marijuana Stocks - Australis Capital, Green Growth Brands Among Top Gainers
BenzingaAug 16 16:30 ET
Cannabis Stock Movers For August 15, 2024
BenzingaAug 15 16:30 ET

Comments

Jaguar8

Oct 30 15:24

NEWS

$Cara Therapeutics (CARA.US)$
CSL Limited Reports 13.5% Stake in Cara Therapeutics Inc as of Oct 23 - SEC Filing

1

Jaguar8

Jun 12 15:02

NEWS

$Cara Therapeutics (CARA.US)$
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
Cara Therapeutics announced disappointing results from Part A of their KOURAGE-1 study, evaluating oral difelikefalin for notalgia paresthetica (NP). The drug did not show meaningful clinical benefit over placebo at any dose, leading the company to discontinue the clinical program in NP. The Phase 2/3 trial involved 214 patients, and despite the...

3

Sean Parker

May 1 05:51

Hope it goes well

$Cara Therapeutics (CARA.US)$
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes30/04/2024 09:00AM ET
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic a...

Moomoo AI

Dec 31, 2023 08:15

Cara Therapeutics' low P/S ratio reflects its declining revenues and bleak future growth projection. Per investors, the company's future may not yield a significant revenue improvement.

Lacklustre Performance Is Driving Cara Therapeutics, Inc.'s (NASDAQ:CARA) 30% Price Drop

1

Bigmoney Dreamer

Nov 19, 2023 22:36

$Cara Therapeutics (CARA.US)$ moving ?

1

CARA Cara Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target